Significant methemoglobinemia with bovine hemoglobin infusion in a case with severe autoimmune hemolytic anemia

1. Goodell AJ, Bloch EM, Simon MS, et al. Babesia screening: the importance of reporting and calibration in cost-effectiveness models. Transfusion 2016;56:000-00. 2. Bish EK, Moritz ED, El-Amine H, et al. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies. Transfusion 2015;55:2256-71. 3. Johnson S, Cable R, Leiby D. Lookback investigations of Babesia microti–seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012;52: 1509-16. 4. Brandt F, Healy GR, Welch M. Human babesiosis: the isolation of Babesia microti in golden hamsters. J Parasitol 1977; 63:934-7. 5. Cullen J, Levine J. Pathology of experimental Babesia microti infection in the Syrian hamster. Lab Anim Sci 1987; 37:640-3. 6. Gleason JN, Healy G, Western K, et al. The “gray” strain of Babesia microti from a human case established in laboratory animals. J Parasitol 1970;56:1256-7. 7. Dodd RY. Germs, gels and genomes: a personal recollection of 30 years in blood safety-testing. In: Stramer SL, editor. Blood safety in the new millennium. Bethesda: American Association of Blood Banks; 2001. p. 99-121. 8. Agapova M, Busch MP, Custer B. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010;50:2220-32.